• Sandoz gains rights to three established brands sold in more than 100 markets
• Transaction, including leading global brand Zinnat®, complements Sandoz leadership in generic penicillins with leading position in cephalosporins
• Acquisition confirms Sandoz commitment to antibiotics, following announcement of further investment plans for European-based manufacturing network

Basel, October 11, 2021 – Sandoz, a Novartis division, has successfully completed the acquisition of GSK’s cephalosporin antibiotics business.

…